People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Idenix Pharmaceuticals Inc | — | Pharmaceuticals | Series A | $5.0M | $154.9M | 2011 |
David N. Standring at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David N. Standring on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| RONALD C. RENAUD JR. | 1 | 5 |
| Tamar D. Howson | 1 | 3 |
| Wayne T. Hockmeyer | 1 | 2 |
| Robert E. Pelzer | 1 | 1 |
| Charles W. Cramb | 1 | 1 |
| Thomas R. Hodgson | 1 | 1 |
| Maria D. Stahl | 1 | 1 |
| Paul J. Fanning | 1 | 1 |
| Denise E. Pollard-Knight | 1 | 1 |
| Daniella C. Beckman | 1 | 1 |
| Anthony E. Rosenberg | 1 | 1 |
| Douglas J. Mayers | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.